Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
515.00    -5.00 (-0.96%)
Bid:
510.00
Ask:
520.00
Spread: 10.00 (1.961%)
Market Cap: £84.49m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Full Year Trading Statement

26 Jan 2022 07:00

RNS Number : 6308Z
Anpario PLC
26 January 2022
 
Anpario plc("Anpario" or the "Group")

 

Full Year Trading Statement

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2021.

 

Trading update

The Group has delivered a strong operating performance despite a number of challenges in global markets and supply chains due to the pandemic. Earnings are expected to be in line with current market expectations with full year sales expected to be not less than £33m.

 

Sales growth has been achieved across all of our regions, Asia, Europe, Middle-East and Africa (MEA) and the Americas. Some territories are still experiencing weakness linked to the pandemic, particularly in parts of MEA and Asia. However, a number of key market developments have provided MEA with the strongest segment growth, helping it recover from the previous year. The impact in Asia of lock-downs and reduced tourism was more than offset by strong performances in China and Australasia.

 

We have continued to experience increased logistics and raw material price inflation, the cost of which is being passed on through sales price increases. We are seeing some encouraging signs that cost price inflation has begun to stabilise and the improving international travel situation will help our sales teams drive new business development initiatives.

 

The Board would like to thank all stakeholders, especially our staff around the world, who have adapted to new ways of working and put every effort into ensuring continued production and delivery of our products to customers and our subsidiaries around the world.

 

Financial position

Our financial position remains very strong with year-end cash balances of £15.5m (31 Dec 2020: £15.8m). Global logistics challenges led us to absorb cash into working capital, particularly through the first part of the year, to ensure local supply to our customers. Through H2 we have increased cash by £0.9m, after £2.1m of dividend payments and further capital investments of £0.9m, including the Solar Panel installation to reduce our carbon emissions.

 

Final results date

The Group expects to announce its final results for the year ended 31 December 2021 on 16 March 2022.

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUGGGUPPPPA
Date   Source Headline
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding
30th Mar 20213:39 pmRNSDirector/PDMR Shareholding
17th Mar 20217:01 amRNSDirectorate Change
17th Mar 20217:00 amRNSFinal Results
15th Mar 20213:38 pmRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSDirectorate Change
4th Feb 20212:54 pmRNSBlock Listing Application
3rd Feb 20214:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:30 pmRNSTotal Voting Rights
26th Jan 20217:00 amRNSTrading Statement and Board update
25th Jan 20217:00 amRNSDirectorate Change
18th Jan 20217:00 amBUSBlock listing Interim Review
8th Jan 20217:00 amBUSDirectorate change
9th Dec 202010:55 amBUSTotal Voting Rights
5th Nov 20205:03 pmBUSDirector/PDMR Shareholding
3rd Nov 202010:06 amRNSTotal Voting Rights
16th Oct 20201:22 pmRNSLady Oregon Goes Aloft
9th Oct 20207:17 amRNSDirector/PDMR Shareholding
2nd Oct 202012:13 pmRNSTotal Voting Rights
24th Sep 20207:00 amRNSChange of auditor
18th Sep 20204:24 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amBUSHalf-year Report
17th Jul 202010:55 amRNSBlock listing Interim Review
7th Jul 20201:43 pmRNSTotal Voting Rights
3rd Jul 20203:42 pmRNSHolding(s) in Company
3rd Jul 20202:42 pmRNSHolding(s) in Company
25th Jun 20202:13 pmRNSResult of the AGM
25th Jun 20207:00 amRNSAGM Statement
18th Jun 20205:06 pmRNSHolding(s) in Company
1st May 20205:43 pmBUSNotice of AGM
1st May 202010:16 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCOVID-19 Update and Patent Application
7th Apr 20208:45 amRNSTotal Voting Rights
18th Mar 20207:00 amBUSFinal Results
13th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20207:00 amRNSCompletion of Buyback Programme
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 20207:00 amRNSTransaction in Own Shares
25th Feb 20207:00 amRNSTransaction in Own Shares
24th Feb 20207:00 amRNSTransaction in Own Shares
20th Feb 20203:11 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSTransaction in Own Shares
12th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20203:31 pmRNSHolding(s) in Company
7th Feb 202011:16 amRNSHolding(s) in Company
7th Feb 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.